These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37375725)

  • 1. Asymmetric Lipid Vesicles: Techniques, Applications, and Future Perspectives as an Innovative Drug Delivery System.
    Gardea-Gutiérrez D; Núñez-García E; Oseguera-Guerra BE; Román-Aguirre M; Montes-Fonseca SL
    Pharmaceuticals (Basel); 2023 May; 16(6):. PubMed ID: 37375725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constant pressure-controlled extrusion method for the preparation of Nano-sized lipid vesicles.
    Morton LA; Saludes JP; Yin H
    J Vis Exp; 2012 Jun; (64):. PubMed ID: 22760481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivesicular Liposome: A Lipid-based Drug Delivery System for Efficient Drug Delivery.
    Gorain B; Al-Dhubiab BE; Nair A; Kesharwani P; Pandey M; Choudhury H
    Curr Pharm Des; 2021; 27(43):4404-4415. PubMed ID: 34459377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of liposomes as drug delivery system for therapeutic applications.
    Guimarães D; Cavaco-Paulo A; Nogueira E
    Int J Pharm; 2021 May; 601():120571. PubMed ID: 33812967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into Asymmetric Liposomes as a Potential Intervention for Drug Delivery Including Pulmonary Nanotherapeutics.
    Al Badri YN; Chaw CS; Elkordy AA
    Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Mini-review Based on Multivesicular Liposomes: Composition, Design, Preparation, Characteristics, and Therapeutic Importance as DEPOFOAM
    Sreelaya P; Bhattacharya S
    Curr Pharm Biotechnol; 2023; 24(12):1479-1488. PubMed ID: 36722484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane Structure-Function Insights from Asymmetric Lipid Vesicles.
    London E
    Acc Chem Res; 2019 Aug; 52(8):2382-2391. PubMed ID: 31386337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical characterization of liposomes and other lipid nanoparticles for drug delivery.
    Fan Y; Marioli M; Zhang K
    J Pharm Biomed Anal; 2021 Jan; 192():113642. PubMed ID: 33011580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Size and structure of spontaneously forming liposomes in lipid/PEG-lipid mixtures.
    Rovira-Bru M; Thompson DH; Szleifer I
    Biophys J; 2002 Nov; 83(5):2419-39. PubMed ID: 12414678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and Drug Entrapment Properties of Asymmetric Liposomes Containing Cationic and Anionic Lipids.
    Li B; London E
    Langmuir; 2020 Oct; 36(42):12521-12531. PubMed ID: 33070610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches to Address PK-PD Challenges of Conventional Liposome Formulation with Special Reference to Cancer, Alzheimer's, Diabetes, and Glaucoma: An Update on Modified Liposomal Drug Delivery System.
    Kesharwani P; Kumari K; Gururani R; Jain S; Sharma S
    Curr Drug Metab; 2022; 23(9):678-692. PubMed ID: 35692131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethosomes and Transfersomes: Principles, Perspectives and Practices.
    Garg V; Singh H; Bimbrawh S; Singh SK; Gulati M; Vaidya Y; Kaur P
    Curr Drug Deliv; 2017; 14(5):613-633. PubMed ID: 27199229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of liposomes with mammalian cells.
    Pagano RE; Weinstein JN
    Annu Rev Biophys Bioeng; 1978; 7():435-68. PubMed ID: 352245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposome-nanogel structures for future pharmaceutical applications.
    Kazakov S; Levon K
    Curr Pharm Des; 2006; 12(36):4713-28. PubMed ID: 17168774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of different lipid components on the in vitro stability and release kinetics of liposome formulations.
    Anderson M; Omri A
    Drug Deliv; 2004; 11(1):33-9. PubMed ID: 15168789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atomic force microscopy: a tool to study the structure, dynamics and stability of liposomal drug delivery systems.
    Spyratou E; Mourelatou EA; Makropoulou M; Demetzos C
    Expert Opin Drug Deliv; 2009 Mar; 6(3):305-17. PubMed ID: 19327046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of liposome formulation parameters and their influence on encapsulation, stability and drug release in glibenclamide liposomes.
    Maritim S; Boulas P; Lin Y
    Int J Pharm; 2021 Jan; 592():120051. PubMed ID: 33161039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems.
    Patel GB; Sprott GD
    Crit Rev Biotechnol; 1999; 19(4):317-57. PubMed ID: 10723627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential oils encapsulated in liposomes: a review.
    Sherry M; Charcosset C; Fessi H; Greige-Gerges H
    J Liposome Res; 2013 Dec; 23(4):268-75. PubMed ID: 23879218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of liposomes as injectable-drug delivery systems.
    Ostro MJ; Cullis PR
    Am J Hosp Pharm; 1989 Aug; 46(8):1576-87. PubMed ID: 2672806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.